IFNG and neoplasm: These cells respond to tumor-specific antigens by producing effector cytokines like IFN-γ and tumor necrosis factor-alpha (TNF-α), which stimulate cytotoxic activity and enhance the recruitment of other immune cells, such as CD8+ T cells and natural killer cells, to the tumor site.